ATRA — Atara Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Atara Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	371	243	51.7	42.5	8.48
Net Total Accounts Receivable
Net Total Receivables	0.986	40.2	34.1	1.48	1.25
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	385	295	102	64.9	12.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	79.9	74.3	58.8	41.1	7.14
Other Long Term Assets
Total Assets	468	376	166	109	20.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	106	78.9	142	135	14.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	189	250	265	206	58.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	280	127	-99.2	-97.3	-38.5
Total Liabilities & Shareholders' Equity	468	376	166	109	20.2
Total Common Shares Outstanding